Cargando…
Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1
BACKGROUND: Influenza H5N1 is one subtype of the influenza A virus which can infect human bodies and lead to death. Timely diagnosis before its breakout is vital to the human health. The current clinical biochemical diagnosis for influenza virus are still flawed, and the diagnostic kits of H5N1 are...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274719/ https://www.ncbi.nlm.nih.gov/pubmed/25526777 http://dx.doi.org/10.1186/s12967-014-0352-5 |
_version_ | 1782350025824665600 |
---|---|
author | Zhu, Min Gong, Xue Hu, Yonghong Ou, Weijun Wan, Yakun |
author_facet | Zhu, Min Gong, Xue Hu, Yonghong Ou, Weijun Wan, Yakun |
author_sort | Zhu, Min |
collection | PubMed |
description | BACKGROUND: Influenza H5N1 is one subtype of the influenza A virus which can infect human bodies and lead to death. Timely diagnosis before its breakout is vital to the human health. The current clinical biochemical diagnosis for influenza virus are still flawed, and the diagnostic kits of H5N1 are mainly based on traditional monoclonal antibodies that hardly meet the requirements for clinical applications. Nanobody is a promising tool for diagnostics and treatment due to its smallest size, high specificity and stability. In this study, a novel Nanobody-based bioassay was developed for rapid, low-cost and sensitive detection of the influenza H5N1 virus. METHODS: Nanobodies specific to H5N1 virus were selected from a VHH library by phage display technology. In this system, the biotinylated Nanobody was directionally captured by streptavidin coated on ELISA plate, which can specifically capture the H5N1 virus. Another Nanobody conjugated with HRP was used as a detector. A novel directional enzyme-linked immunosorbent assay for H5N1 using specific Nanobodies was established and compared to the conventional undirected ELISA assay. RESULTS: We have successfully constructed a high quality phage display Nanobody library and isolated two Nanobodies against H5N1 with high affinity and specificity. These two Nanobodies were further used to prepare the biosensor detection system. This streptavidin-biotin-based directional double Nanobodies sandwich ELISA for H5N1 detection showed superiority over the commonly undirectional ELISA protocol. The linear range of detection for standards in this immunoassay was approximately 50–1000 ng/mL and the detection limit was 14.1 ng/mL. The average recoveries of H5N1 virus from human serum samples were in the range from 94.58% to 114.51%, with a coefficient of variation less than 6.5%. CONCLUSION: Collectively, these results demonstrated that the proposed detection system is an alternative diagnostic tool that enables a rapid, inexpensive, sensitive and specific detection of the influenza virus. |
format | Online Article Text |
id | pubmed-4274719 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-42747192014-12-24 Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1 Zhu, Min Gong, Xue Hu, Yonghong Ou, Weijun Wan, Yakun J Transl Med Research BACKGROUND: Influenza H5N1 is one subtype of the influenza A virus which can infect human bodies and lead to death. Timely diagnosis before its breakout is vital to the human health. The current clinical biochemical diagnosis for influenza virus are still flawed, and the diagnostic kits of H5N1 are mainly based on traditional monoclonal antibodies that hardly meet the requirements for clinical applications. Nanobody is a promising tool for diagnostics and treatment due to its smallest size, high specificity and stability. In this study, a novel Nanobody-based bioassay was developed for rapid, low-cost and sensitive detection of the influenza H5N1 virus. METHODS: Nanobodies specific to H5N1 virus were selected from a VHH library by phage display technology. In this system, the biotinylated Nanobody was directionally captured by streptavidin coated on ELISA plate, which can specifically capture the H5N1 virus. Another Nanobody conjugated with HRP was used as a detector. A novel directional enzyme-linked immunosorbent assay for H5N1 using specific Nanobodies was established and compared to the conventional undirected ELISA assay. RESULTS: We have successfully constructed a high quality phage display Nanobody library and isolated two Nanobodies against H5N1 with high affinity and specificity. These two Nanobodies were further used to prepare the biosensor detection system. This streptavidin-biotin-based directional double Nanobodies sandwich ELISA for H5N1 detection showed superiority over the commonly undirectional ELISA protocol. The linear range of detection for standards in this immunoassay was approximately 50–1000 ng/mL and the detection limit was 14.1 ng/mL. The average recoveries of H5N1 virus from human serum samples were in the range from 94.58% to 114.51%, with a coefficient of variation less than 6.5%. CONCLUSION: Collectively, these results demonstrated that the proposed detection system is an alternative diagnostic tool that enables a rapid, inexpensive, sensitive and specific detection of the influenza virus. BioMed Central 2014-12-20 /pmc/articles/PMC4274719/ /pubmed/25526777 http://dx.doi.org/10.1186/s12967-014-0352-5 Text en © Zhu et al.; licensee BioMed Central. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Zhu, Min Gong, Xue Hu, Yonghong Ou, Weijun Wan, Yakun Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1 |
title | Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1 |
title_full | Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1 |
title_fullStr | Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1 |
title_full_unstemmed | Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1 |
title_short | Streptavidin-biotin-based directional double Nanobody sandwich ELISA for clinical rapid and sensitive detection of influenza H5N1 |
title_sort | streptavidin-biotin-based directional double nanobody sandwich elisa for clinical rapid and sensitive detection of influenza h5n1 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274719/ https://www.ncbi.nlm.nih.gov/pubmed/25526777 http://dx.doi.org/10.1186/s12967-014-0352-5 |
work_keys_str_mv | AT zhumin streptavidinbiotinbaseddirectionaldoublenanobodysandwichelisaforclinicalrapidandsensitivedetectionofinfluenzah5n1 AT gongxue streptavidinbiotinbaseddirectionaldoublenanobodysandwichelisaforclinicalrapidandsensitivedetectionofinfluenzah5n1 AT huyonghong streptavidinbiotinbaseddirectionaldoublenanobodysandwichelisaforclinicalrapidandsensitivedetectionofinfluenzah5n1 AT ouweijun streptavidinbiotinbaseddirectionaldoublenanobodysandwichelisaforclinicalrapidandsensitivedetectionofinfluenzah5n1 AT wanyakun streptavidinbiotinbaseddirectionaldoublenanobodysandwichelisaforclinicalrapidandsensitivedetectionofinfluenzah5n1 |